Bionaut Labs
Biotechnology ResearchCalifornia, United States11-50 Employees
Bionauts™ are remote-controlled micro-robots revolutionizing the treatment of central nervous system disorders, targeting deep brain structures safely and precisely
Innovative Technology Bionaut Labs develops cutting-edge micro-robotic solutions for CNS disorders, presenting opportunities to collaborate with hospitals, research institutions, and medical device providers seeking advanced targeted treatment options.
Funding Momentum With over 63 million dollars raised through strategic investments by Khosla Ventures and others, Bionaut Labs is poised for rapid expansion and product development, making it an ideal partner for investors, contract manufacturers, and commercialization services.
Specialized Market Fit Operating within the biotech sector focused on precision medicine for brain diseases, the company offers tailored solutions that can appeal to pharmaceutical companies, clinical research organizations, and healthcare providers aiming to enhance treatment efficacy.
Growth Potential Despite a relatively small team, Bionaut Labs shows significant growth, signaling opportunities for suppliers and service providers in research, testing, and manufacturing support to scale their solutions alongside the company's development milestones.
Expertise & Leadership With key personnel and advisors from prominent biotech and pharma backgrounds, Bionaut Labs presents opportunities to engage with experienced professionals and leverage their leadership network for strategic partnerships and pilot programs.
Bionaut Labs uses 8 technology products and services including Simulink, Open Graph, MySQL, and more. Explore Bionaut Labs's tech stack below.
| Bionaut Labs Email Formats | Percentage |
| First.Last@bionautlabs.com | 88% |
| Last@bionautlabs.com | 9% |
| First@bionautlabs.com | 1% |
| F-Last@bionautlabs.com | 2% |
Biotechnology ResearchCalifornia, United States11-50 Employees
Bionauts™ are remote-controlled micro-robots revolutionizing the treatment of central nervous system disorders, targeting deep brain structures safely and precisely
Bionaut Labs has raised a total of $43M of funding over 5 rounds. Their latest funding round was raised on Nov 28, 2022 in the amount of $43M.
Bionaut Labs's revenue is estimated to be in the range of $10M$25M
Bionaut Labs has raised a total of $43M of funding over 5 rounds. Their latest funding round was raised on Nov 28, 2022 in the amount of $43M.
Bionaut Labs's revenue is estimated to be in the range of $10M$25M